Medication

An evangelical pastor prays for Brazil's President Jair Bolsonaro, who said he tested positive for COVID-19, outside Alvorada Palace, the president's official residence in Brasilia, Brazil, Tuesday, July 7, 2020. (AP Photo/Eraldo Peres)
July 09, 2020 - 9:54 am
RIO DE JANEIRO (AP) — After months of touting an unproven anti-malaria drug as a treatment for the new coronavirus, Brazilian President Jair Bolsonaro is turning himself into a test case live before millions of people as he swallows hydroxychloroquine pills on social media and encourages others to...
Read More
FILE - In this May 25, 2020, file photo, Brazil's President Jair Bolsonaro, wearing a face mask amid the coronavirus pandemic, stands among supporters as he leaves his official residence of Alvorada palace in Brasilia, Brazil. Bolsonaro said Tuesday, July 7, he tested positive for COVID-19 after months of downplaying the virus's severity while deaths mounted rapidly inside the country. (AP Photo/Eraldo Peres, File)
July 08, 2020 - 7:59 pm
RIO DE JANEIRO (AP) — After months of touting an unproven anti-malaria drug as a treatment for the new coronavirus, Brazilian President Jair Bolsonaro is turning himself into a test case live before millions of people as he swallows hydroxychloroquine pills on social media and encourages others to...
Read More
July 07, 2020 - 9:00 am
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday. The case needs independent verification and it’s way...
Read More
FILE - In this Dec. 1, 2018, file photo, Indians participate in a health awareness run to mark World AIDS Day in Hyderabad, India. New numbers on the global AIDS epidemic show some big successes such as fewer deaths and new infections. But there are also some tragic failures: Only half of children with HIV, the virus that causes the disease, are getting treatment. UNAIDS, a United Nations agency, reported last year's numbers Monday, July 6, 2020, at the start of an international AIDS conference. (AP Photo/Mahesh Kumar A., File)
July 06, 2020 - 10:41 am
New numbers on the global AIDS epidemic show some big successes, such as fewer deaths and new infections. But there are also some tragic failures: Only half the children with HIV, the virus that causes the disease, are getting treatment. “We are making great progress against the HIV epidemic .....
Read More
In this June 5, 2020 photo provided by the Mountain Area Health Education Center, physicians, residents and staff from the facility in Asheville, N.C., take a knee to show support for renewed calls for racial justice after the police killing of George Floyd. Government statistics from late January through May 30 suggest an increase in U.S. deaths from chronic diseases compared with historical trends. They include 7,000 excess deaths from hypertension, about 4,000 from diabetes and 3,000 from strokes -- all conditions that disproportionately affect Blacks, although the data don’t include race. (Brenda Benik/MAHEC via AP)
July 05, 2020 - 10:07 am
Doctors have known it for a long time, well before the resounding cries of “Black Lives Matter”: Black people suffer disproportionately. They face countless challenges to good health, among them food, transportation and income. The stress of living with racism has very real, physical effects. And...
Read More
Sex workers wait for clients in the red light district of Harare, Zimbabwe, Friday, June 12, 2020. As the coronavirus spreads in Africa, it increasingly threatens those who earn their living on the streets, including sex workers with HIV. (AP Photo/Tsvangirayi Mukwazhi)
July 04, 2020 - 4:02 am
KIGALI, Rwanda (AP) — As the coronavirus spreads in Africa, it threatens in multiple ways those who earn their living on the streets — people like Mignonne, a 25-year-old sex worker with HIV. The lockdown in Rwanda has kept many of her customers away, she said, so she has less money to buy food...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
July 01, 2020 - 6:11 pm
LONDON (AP) — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir for the next...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
June 29, 2020 - 11:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
Residents wearing masks to curb the spread of the coronavirus ride past a neighborhood under lockdown in Beijing Tuesday, June 16, 2020. Chinese authorities locked down a third neighborhood in Beijing on Tuesday as they rushed to prevent the spread of a new coronavirus outbreak that has infected more than 100 people in a country that appeared to have largely contained the virus. (AP Photo/Ng Han Guan)
AP News
June 16, 2020 - 10:31 pm
ATLANTA (AP) — As nations grapple with new outbreaks and spiking death tolls from the coronavirus, a commonly available drug appeared Tuesday to offer hope that the most seriously ill could have a better chance of survival. The pandemic has forced countries to impose lockdowns and tough...
Read More
Packages of Dexamethasone are displayed in a pharmacy, Tuesday, June 16, 2020, in Omaha, Neb. Researchers in England said Tuesday they have the first evidence that the drug can improve COVID-19 survival. The cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. (AP Photo/Nati Harnik)
June 16, 2020 - 3:59 pm
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients. The results were announced Tuesday and the British government immediately authorized the drug...
Read More

Pages